LumiraDx to Announce First Quarter Financial Results and Host Quarterly Conference Call on May 11
LumiraDx Limited (Nasdaq: LMDX) has announced that it will release its first quarter financial results on May 11, 2022. The company will hold a conference call and webcast at 4:30 PM Eastern Time to discuss these results and highlight key business developments. Investors and analysts can access the call via a dedicated phone line or online, and a replay will be available on LumiraDx's investor website shortly after the call concludes. This session aims to provide insights into the company's performance in the first quarter of 2022.
- None.
- None.
LONDON, April 29, 2022 /PRNewswire/ -- LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care (POC) diagnostics company, announced it will release its first quarter financial results on Wednesday, May 11, 2022. On the day of the release, LumiraDx will host a conference call and webcast at 4:30 PM Eastern Time to review the financial results and business highlights.
Event: | LumiraDx First Quarter 2022 Financial Results Conference Call |
Date: | Wednesday, May 11, 2022 |
Time: | 4:30 PM Eastern Time |
Live Call/Webcast: | (877) 270-2148 (Domestic), (412) 902-6510 (International) |
Conference ID: 10166789 | |
https://investors.lumiradx.com/news-and-events/investor-calendar |
A replay of the webcast will be available on the Investor's section of the company's website at investors.lumiradx.com shortly after the conclusion of the call. The webcast will be archived for one year.
About LumiraDx
LumiraDx (Nasdaq: LMDX) is a next-generation point of care diagnostics company that is transforming community-based healthcare. Founded in 2014, LumiraDx manufactures and commercializes an innovative diagnostic Platform that supports a broad menu of tests with lab comparable performance at the point of care. LumiraDx diagnostic testing solutions are being deployed by governments and leading healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools, and workplaces to screen, diagnose, and monitor wellness as well as disease. LumiraDx has, on the market and in development, 30+ tests covering infectious diseases, cardiovascular diseases, diabetes, and coagulation disorders, all on the LumiraDx Platform. In addition, LumiraDx has a comprehensive portfolio of fast, accurate, and cost-efficient COVID-19 testing solutions from the lab to point of need.
LumiraDx is based in the UK with more than 1600 employees worldwide. Further information on LumiraDx and the LumiraDx Platform is available at www.lumiradx.com
Contact:
Colleen McMillen
Colleen.McMillen@lumiradx.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/lumiradx-to-announce-first-quarter-financial-results-and-host-quarterly-conference-call-on-may-11-301536039.html
SOURCE LumiraDx
FAQ
When will LumiraDx announce its first quarter financial results?
What time is the LumiraDx conference call for the first quarter results?
How can I access the LumiraDx financial results conference call?
Will there be a replay of the LumiraDx financial results call?
